Other

Share of other comprehensive (loss) income from Brookfield Asset Management ULC

West Pharmaceutical Services Share of other comprehensive (loss) income from Brookfield Asset Management ULC increased by 100.0% to $0.00 in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 100.0%, from $100.00K to $0.00.

Analysis

StatementIncome Statement
SectionOther
First reportedQ2 2023
Last reportedQ1 2026Apr 23, 2026
Metric ID: other_oci_equity_method_investment_after_tax_parent

Historical Data

9 periods
 Q2 '23Q3 '23Q1 '24Q2 '24Q3 '24Q1 '25Q2 '25Q3 '25Q1 '26
Value-$100.00K$0.00-$100.00K-$100.00K$200.00K$100.00K$100.00K-$100.00K$0.00
QoQ Change—+100.0%—+0.0%+300.0%-50.0%+0.0%-200.0%+100.0%
YoY Change———+0.0%—+200.0%+200.0%-150.0%-100.0%
Range-$100.00K – $200.00K
CAGR-100.0%
Avg YoY Growth+30.0%
Median YoY Growth+0.0%

Frequently Asked Questions

What is West Pharmaceutical Services's share of other comprehensive (loss) income from brookfield asset management ulc?
West Pharmaceutical Services (WST) reported share of other comprehensive (loss) income from brookfield asset management ulc of $0.00 in Q1 2026.
How has West Pharmaceutical Services's share of other comprehensive (loss) income from brookfield asset management ulc changed year-over-year?
West Pharmaceutical Services's share of other comprehensive (loss) income from brookfield asset management ulc decreased by 100.0% year-over-year, from $100.00K to $0.00.